NOTIFICATION REGARDING CHANGES IN CARDIOMETABOLIC TESTING

December 18, 2018

We want to inform you of a change in our sample handling procedures for orders requesting Cardiometabolic (CMR) testing. This change will be effective 12/18/2018.

We use the test results to assess risk for developing cardiovascular disease and/or type 2 diabetes.  Results are most informative if derived from samples drawn at the same time. 

Previously, if any part of the CMR sample was unacceptable for testing, the entire CMR order would be rejected and a redraw will be requested. This has posed a hardship on some clients due to the temperature requirement of some assays, and the goal of the policy change is to provide test results where possible.

Beginning December 18, 2018, if any part of the CMR sample is acceptable for testing, the CMR order will be partially fulfilled for the assays that can be performed.  Resubmission of samples drawn on a different day can not be calculated into overall risk assessments. Example: if no purple top tube is received with the SST tube(s), there will be no test results for Hemoglobin A1C and the Omega Check and no risk assessment report on the CMR. If the purple top is drawn and sent at a later date, the results for Hemoglobin A1C and the Omega Check will be reported and billed as independent tests and not as part of the CMR panel.

Please contact Customer Support Services at 1-800-227-5227 (option 2) regarding any questions you may have on this policy change.

We appreciate your business and look forward to serving you in the future!

NOTIFICATION REGARDING SAMPLE ACCEPTANCE/STABILITY CRITERIA

July 26, 2018

We would like to inform you of an update to our sample acceptance/stability criteria. Please note the following acceptance criteria will be effective August 1, 2018.  

SpectraCell Laboratories regularly reviews procedures and policies to ensure that we continue to provide the best in laboratory medicine. We recently reviewed our policies for sample acceptance based on stability criteria for our test menu. These updates will ensure that samples received under the following circumstances are suitable for further processing.  

Please contact Customer Support Services at 1-­‐800-­‐227-­‐5227 (option 4) if you have questions.

We appreciate your business and look forward to serving you in the future!

Phuc Nguyen, BS MT(ASCP)
QA/QC Director

NOTIFICATION REGARDING CHANGES IN PROCESSING OF “TEST IN QUESTION” SAMPLES

April 26, 2018

We would like to inform you of changes in our sample handling procedures for orders where the requested laboratory testing is either not indicated or is ambiguous on the requisition. This change will be effective May 1, 2018.

When samples are received at SpectraCell Laboratories and the requested testing is not indicated:

  • We will contact the ordering provider’s office the day of receipt for instructions before proceeding.
  • If we cannot resolve the Test in Question (TIQ) on the day of receipt, samples that can be held will be stored under appropriate conditions until the TIQ can be resolved or the sample exceeds established stability limits.
  • Our Micronutrient Test (MNT) is performed on living cells and sample stability is very limited. If we cannot resolve an MNT TIQ on the day of receipt (by 3:00 pm US Central Time), the sample will be rejected, and no testing will be performed.

This process change will ensure that we provide you with the most accurate laboratory results for the tests of interest.

Please contact Customer Support Services at 1-800-227-5227 (option 4) if you have questions.

We appreciate your business and look forward to serving you in the future!


Thank you.
James W. Jacobson, Ph.D.
Vice President and Chief Scientific Officer

NOTIFICATION REGARDING CHANGES IN CARDIOMETABOLIC TESTING

January 18, 2018

We want to inform you of a change in our sample handling procedures for orders requesting Cardiometabolic (CM) testing. This change will be effective 1/29/2018.

We use the test results to assess risk for developing cardiovascular disease and/or type 2 diabetes.  Results are most informative if derived from the same time point.  Beginning on the effective date shown above, if any part of the CM sample is unacceptable for testing, the entire CM order will be rejected and a redraw will be requested.  This process change will ensure that we provide you with the most accurate laboratory data for assessing cardiometabolic risk.

Please contact Customer Support Services at 1-800-227-5227 (option 4) if you have questions.

We appreciate your business and look forward to serving you in the future!

Thank you.
James W. Jacobson, Ph.D.
Vice President and Chief Scientific Officer

NOTIFICATION REGARDING AUTOMATIC ENROLLMENT FOR BORDERLINE REPORTING

June 28, 2016

We want to inform you of a change in our Micronutrient test report. This change will be effective 7/1/2016.

In addition to flagging the test components indicating nutritional deficiencies, we will also be highlighting borderline values – those test components approaching deficiency status that you may find informative in clinical management of your patients.

If you do not want borderline values identified on your patient reports, you may opt out by contacting your SpectraCell sales representative or Customer Support Services at 1-800-227-5227 (option 4).

We appreciate your business and look forward to serving you in the future!

Thank you.